Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis

This publication has 31 references indexed in Scilit:

• Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network
  Blood, 2005
• Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
  New England Journal of Medicine, 2004
• Randomized Study to Evaluate the Use of High-Dose Therapy as Part of Primary Treatment for “Aggressive” Lymphoma
  Journal of Clinical Oncology, 2002
• Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation
  Bone Marrow Transplantation, 2001
• Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (⩾60 years) with non-Hodgkin’s lymphoma: comparison with patients <60 years treated within the same protocol
  Bone Marrow Transplantation, 2000
• Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report
  Bone Marrow Transplantation, 1999
• Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study
  Bone Marrow Transplantation, 1998
• Peripheral stem cell mobilization and engraftment in patients over age 60
  Bone Marrow Transplantation, 1997
• Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age
  Bone Marrow Transplantation, 1997
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995